Related references
Note: Only part of the references are listed.Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy
Zimo Liu et al.
ACTA PHARMACEUTICA SINICA B (2023)
Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice
Mohamed Ibrahim et al.
JOURNAL OF CONTROLLED RELEASE (2023)
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
Alaeddin Khalil et al.
HAEMATOLOGICA (2022)
Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
Mariona Estape Senti et al.
JOURNAL OF CONTROLLED RELEASE (2022)
The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers
Wufa Fan et al.
ACTA PHARMACEUTICA SINICA B (2022)
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Yi Ju et al.
ACS NANO (2022)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
BNT162b2 mRNA COVID-19 Vaccine: First Approval
Yvette N. Lamb
DRUGS (2021)
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
Linde Schoenmaker et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Multifunctional biomolecule nanostructures for cancer therapy
Jing Wang et al.
NATURE REVIEWS MATERIALS (2021)
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
Bing-Mae Chen et al.
ACS NANO (2021)
Formulation of Metal-Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility
Xu Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
Even Chen et al.
ACS NANO (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice
Nehal E. Elsadek et al.
MOLECULAR PHARMACEUTICS (2020)
A review on various analytical methods for determination of anthracyclines and their metabolites as anti-cancer chemotherapy drugs in different matrices over the last four decades
Yaser Pashaei et al.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY (2020)
Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications
Karim A. Soliman et al.
DRUG DISCOVERY TODAY (2019)
A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum
Christopher Ehlinger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Poloxamer Hydrogels for Biomedical Applications
Eleonora Russo et al.
PHARMACEUTICS (2019)
Poloxamer 407/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery
Maria A. Grimaudo et al.
MOLECULAR PHARMACEUTICS (2018)
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
Yuan-Chin Hsieh et al.
THERANOSTICS (2018)
Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation
Hao Zhou et al.
ACS NANO (2018)
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Elena Giuliano et al.
PHARMACEUTICS (2018)
In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models
Yu Liu et al.
ACTA PHARMACEUTICA SINICA B (2017)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang et al.
ANALYTICAL CHEMISTRY (2016)
Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals
Bing-Mae Chen et al.
ANALYTICAL CHEMISTRY (2016)
Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications
Anisha A. D'souza et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
In situ gelling systems based on Pluronic F127/Pluronic F68 formulations for ocular drug delivery
Kosai Al Khateb et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
Thomas J. Povsic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
Yu Mima et al.
MOLECULAR PHARMACEUTICS (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Safety Evaluation of Polyethylene Glycol (PEG) Compounds for Cosmetic Use
Hyun-Jun Jang et al.
TOXICOLOGICAL RESEARCH (2015)
Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial
Nicola Longo et al.
LANCET (2014)
Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production
Wei Yang et al.
NANO TODAY (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview
Hugo Almeida et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Amr S. Abu Lila et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Immunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Narendra Chirmule et al.
AAPS JOURNAL (2012)
Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective
S. M. Moghimi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Differential Uptake of Functionalized Polystyrene Nanoparticles by Human Macrophages and a Monocytic Cell Line
Oleg Lunov et al.
ACS NANO (2011)
Nanoparticle PEGylation for imaging and therapy
Jesse V. Jokerst et al.
NANOMEDICINE (2011)
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Che-Ming J. Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Katrin Knop et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
PEG-modified biopharmaceuticals
Pascal Bailon et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
A review of poloxamer 407 pharmaceutical and pharmacological characteristics
Gilles Dumortier et al.
PHARMACEUTICAL RESEARCH (2006)
Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin-encapsulation and high-dose first injection
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)
Alisar S. Zahr et al.
LANGMUIR (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
The expression and roles of Toll-like receptors in the biology of the human neutrophil
LC Parker et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Solubilizing excipients in oral and injectable formulations
RG Strickley
PHARMACEUTICAL RESEARCH (2004)
Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs
G Garratty
TRANSFUSION MEDICINE REVIEWS (2004)
Oral sodium phosphate solution - A review of its use as a colorectal cleanser
MP Curran et al.
DRUGS (2004)
Causative factors behind poloxamer 188 (pluronic F68, Flocor™)-induced complement activation in human sera.: A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels
SM Moghimi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Structure-immunogenicity relationships of therapeutic proteins
S Hermeling et al.
PHARMACEUTICAL RESEARCH (2004)
Fractionation of cells and subcellular particles with Percoll
H Pertoft
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS (2000)
A simple method for human peripheral blood monocyte isolation
MC de Almeida et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2000)
Share Paper
